SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-18-006805
Filing Date
2018-10-02
Accepted
2018-10-02 06:30:17
Documents
2
Period of Report
2018-10-02

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_100118.htm 6-K 4824
2 PRESS RELEASE exh_991.htm EX-99.1 5724
  Complete submission text file 0001171843-18-006805.txt   11598
Mailing Address 4150 ST CATHERINE STREET WEST SUITE 550 MONTREAL A8 H3Z 2Y5
Business Address 4150 ST CATHERINE STREET WEST SUITE 550 MONTREAL A8 H3Z 2Y5 (514) 940-3600
Clementia Pharmaceuticals Inc. (Filer) CIK: 0001647320 (see all company filings)

IRS No.: 981128564 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38177 | Film No.: 181099287
SIC: 2834 Pharmaceutical Preparations